Supplementary Tables S1-S11 from Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma
Authors:
- Jason R. WestinJWJason R. Westin
- Frederick L. LockeFLFrederick L. Locke
- Michael DickinsonMDMichael Dickinson
- Armin GhobadiAGArmin Ghobadi
- Mahmoud ElsawyMEMahmoud Elsawy
- Tom van MeertenTMTom van Meerten
- David B. MiklosDMDavid B. Miklos
- Matthew L. UlricksonMUMatthew L. Ulrickson
- Miguel-Angel PeralesMPMiguel-Angel Perales
- Umar FarooqUFUmar Farooq
- Luciano WannessonLWLuciano Wannesson
- Lori LeslieLLLori Leslie
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)